4,7,10-TRIOXA-1,13-TRIDECANEDIAMINE
4,7,10-TRIOXA-1,13-TRIDECANEDIAMINE structure
|
Common Name | 4,7,10-TRIOXA-1,13-TRIDECANEDIAMINE | ||
|---|---|---|---|---|
| CAS Number | 4246-51-9 | Molecular Weight | 220.309 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 310.6±0.0 °C at 760 mmHg | |
| Molecular Formula | C10H24N2O3 | Melting Point | -32 °C | |
| MSDS | Chinese USA | Flash Point | 148.0±17.4 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
|
Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry.
J. Chromatogr. A. 1359 , 84-90, (2014) A new approach for proteome-wide profiling drug binding proteins by using monolithic capillary affinity chromatography in combination with HPLC-MS/MS is reported. Two immunosuppresive drugs, namely FK506 and cyclosporin A, were utilized as the experimental mo... |
|
|
Bioorthogonal Labeling, Bioimaging, and Photocytotoxicity Studies of Phosphorescent Ruthenium(II) Polypyridine Dibenzocyclooctyne Complexes.
Chemistry 21 , 10729-40, (2015) The synthesis, characterization, photophysics, lipophilicity, and cellular properties of new phosphorescent ruthenium(II) polypyridine complexes functionalized with a dibenzocyclooctyne (DIBO) or amine moiety [Ru(N^N)2 (L)](PF6 )2 are reported (L=4-(13-N-(3,4... |
|
|
Hollow Mesoporous Silica Nanocarriers with Multifunctional Capping Agents for In Vivo Cancer Imaging and Therapy.
Small 12 , 360-70, (2016) Efficient drug loading and selectivity in drug delivery are two key features of a good drug-carrier design. Here we report on such a drug carrier formed by using hollow mesoporous silica nanoparticles (HMS NPs) as the core and specifically designed multifunct... |